Abstract Medicinal plants from the Egyptian Sinai Peninsula are widely used in traditional Bedouin medicine to treat a range of conditions including cancer, and as such are a promising resource for novel anti-cancer compounds. To achieve scientific justification of traditional use and/or to recommend the use of those plants as medicinal herbs for cancer chemoprevention, a group of 11 Sinai plants of different species that belong to 3 families (Asteraceae, Lamiaceae, and Euphorbiaceae) were biologically screened for cancer preventive activity using the chemoprevention marker enzyme NAD(P)H:quinone oxidoreductase 1 (NQO1). Among the fractions assayed, a solvent extract from Pulicaria incisa had potent NQO1 inducing activity. Further analysis of the mechanism of induction revealed the concentration-dependent stabilization of the transcription factor NF-E2 p45-related factor 2 (Nrf2) and a coordinate upregulation of the Nrf2-dependent enzymes NQO1, heme oxygenase 1 and glutathione S-transferase-Pi. These results establish P. incisa as a promising target for future phytochemical characterization for cancer preventive components.
Introduction
Medicinal plants have been used for thousands of years as traditional treatments, and natural products (NPs) from these plants are still the basis for most modern medicines. Additionally, current studies of these traditional medicines continue to show that they are a rich source of biologically active compounds for the development of new pharmaceutical drug leads [1] [2] [3] . The awareness that one (or more) chemical entity within the plant material is responsible for a particular pharmacological action and can be isolated for use as a single agent began in the nineteenth century in the context of emerging natural science-based medicine and pharmacy [4] . With the vast number of plant species present on the planet, there is a great potential for novel drug discovery since approximately only 1 % have been characterized with respect to their phytochemical composition. Interestingly in many underdeveloped countries, traditional medicines directly extracted from plants are recognized as a rich source of drugs for primary healthcare needs [5] .
The Sinai Peninsula is an epicenter of medicinal plants in the Arabian Desert. Such plant species are referred to as medicinal plants if they have been observed to have biological activity for humans and/or animals or are aromatic plants. The distribution, utilization in folk medicine and active constituents of medicinal plants in Sinai continue to attract the attention of many ecologists, taxonomists and phytochemists [6] [7] [8] [9] [10] [11] . The arid environmental conditions combined with human activity have had a significant impact on the abundance, diversity and distribution of endemic medicinal plants [11] [12] [13] [14] [15] . Wild plant species in Sinai were selected for this study based on the unique ecosystem giving rise to great plant diversity. Geographically, the region is characterized by large variations in landforms, water resources, aridity conditions and temperatures (i.e., cold winters, hot summers, low precipitation and high evaporation). As medicinal plants have been documented as a source of novel metabolites of pharmaceutical and agricultural importance, this study also aimed to give a deeper insight into the 'enigma' of endemic wild plants that are usually used by the Bedouin of the Sinai Peninsula. The findings will be instructive in identifying novel bioactive compounds from selected plants. While chemotherapeutic agents are initially cytotoxic to a variety of tumor cell lines and are effective in treating cancer, drug resistance often develops and is a major cause for discontinuation of a particular therapy [16] . Based on the classified stages of the carcinogenesis process, the field of cancer chemoprevention is defined as the use of relatively non-toxic chemical agents (natural or synthetic) to inhibit, arrest or reverse the carcinogenesis at early stages [17] [18] [19] . The updated WHO Traditional Medicine Strategy for the period 2014-2023 devotes more attention than its predecessor to prioritizing health services and systems, including traditional and complementary medicine products, practices and practitioners. Several studies on the traditional use of Egyptian plants have documented various biological activities, including antibacterial and antifungal [20, 21] , antiviral [22] , cytotoxic [21, 23] , and antioxidant [24] .
The activation of the transcription factor NF-E2 p45-related factor 2 (Nrf2) and the resulting induction of its related gene products have been shown to play a key role in cancer chemoprevention. Many cytoprotective proteins such as NAD(P)H:quinone oxidoreductase 1 (NQO1), heme oxygenase-1 (HO-1) and glutathione S transferases (GSTs) that catalyze the detoxification of procarcinogens and reduce the endogenous levels of toxic reactive oxygen species are commonly transcribed via Nrf2 signalling [25] . NQO1 induction has been used as a marker for the chemopreventive potential of NPs and synthetic chemicals [26] .
As part of our continuing work to investigate and biologically evaluate the Egyptian wild and medicinal plants, the present study aimed to document the ethnomedicinal and/or recommended uses [27] [28] [29] [30] [31] [32] [33] . In the present study, 11 plants from different families were solvent extracted with MeOH:H 2 O (7:3) and CH 2 Cl 2 :MeOH (1:1). A total of 22 extracts were tested using the NQO1 activity screening assay. 
Materials and methods

Plant material and extraction
Eleven plants species were collected in June 2014 from South Sinai, Egypt and aerial parts were air-dried. Plants were identified and voucher specimens were deposited in the Herbarium of Saint Katherine Protectorate, Egypt. The collection was performed under the permission of Saint Katherine Protectorate for scientific purposes and official permission was granted from the National Research Center.
Two batches of the aerial parts (100 g) of each plant were powdered and extracted with CH 2 Cl 2 -MeOH (1:1) and MeOH-H 2 O (7:3) at room temperature. The filtrate solvents extract were concentrated in vacuo using a rotary evaporator to obtain a crude extract, resulting in 22 crude extracts containing compounds with varying polarity.
High-performance liquid chromatography (HPLC) of the non-polar extract from Pulicaria incisa (PI 1:1), which exhibited the most potent NQO1 inducer activity, was performed on an Agilent pump equipped with an Agilent 1200 HPLC instrument with a variable wavelength UV detector at 220 and 254 nm using analytical column YMCPack ODS-A (250 9 4.6 mm i.d.) (Fig. S1 ).
Cell culture
Murine hepatoma Hepa1c1c7 cells (obtained from ATCC Ò , USA) were grown in a-MEM supplemented with 10 % (v/v) heat-and charcoal-inactivated fetal bovine serum. Cells were routinely maintained in a humidified incubator at 37°C, 5 % CO 2 .
Evaluation of NQO1 inducer activity
A quantitative NQO1 microtiter plate assay was used based on previously published protocols [26, 34] . For each experiment, cells (10,000 per well) were plated in 96-well plates. After 24 h, the cell culture medium was replaced with fresh medium containing plant extracts and the cells were incubated for an additional 48 h. Eight replicate wells of seven (0-50 lg/ml) serial dilutions of each plant extract were tested. Plant extracts were prepared as stock solutions in dimethyl sulfoxide (DMSO), and then freshly diluted in the cell culture medium at 1:1,000. The final concentration of DMSO in the medium was maintained at 0.1 % (v/v). At the end of 48-h exposure time, the cells were lysed for 30 min at 25°C in digitonin (0.8 g/l, pH 7.8). The specific activity of NQO1 was evaluated in cell lysates using menadione as a substrate. Protein concentrations were determined in each well using the BCA protein assay (Thermo Scientific, UK). Sulforaphane, a potent classical NQO1 inducer [35] was used as a positive control.
Western blotting for Nrf2 and related targets
For protein expression analysis of the potent NQO1 inducer extract, Hepa1c1c7 cells (overnight incubated monolayers of 3 9 10 5 cells/well in 6-well plates) were treated with three concentrations of the plant extracts (3.125, 12.5 and 50 lg/ml) or vehicle (0.1 % DMSO). Sulforaphane (positive control) in 0.1 % acetonitrile was used as a known inducer of Nrf2 and related target proteins. Cell lysates were prepared in RIPA buffer containing phenylmethylsulfonyl fluoride and protease inhibitor cocktail. Total proteins were measured using BCA assay. Samples were loaded into 10 % Bis-Tris gel and run in 19 MOPS buffer at 150 V for 45 min. Resolved proteins were then transferred to nitrocellulose membranes at 60 V for 2 h. Membranes were blocked in 5 % non-fat milk in phosphate-buffered saline with Tween (PBST) for 1 h at 25°C and then probed overnight (4°C) with primary antibodies against Nrf2, NQO1, HO-1 and GST-Pi (all are generous gifts from John Hayes, University of Dundee, UK). Membranes were probed for b-actin as a loading control. After three washes in PBST (10 min each), membranes were probed with appropriate secondary antibodies for 1 h at 25°C, washed three times in PBST and then developed using enzyme chemiluminescence. Protein bands were visualized using a Bio-Rad Chemidoc Ò Imager.
Results and discussion
Selected plants from Sinai were collected according to endemic and/or ethnobotanical use in traditional medicines. The plants assayed included Achillea fragrantissima (1, AF), Artemisia judaica (2, AJ), Ballota undulata (3, BU), Euphorbia santa-catherine (4, ES), Phlomis aurea (5, PA), Pulicaria incisa (6, PI), Stachys aegyptiaca (7, SA), Pulicaria undulata (8, PU), Seriphidium herba-alba (9, SH), Teucrium polium (10, TP), Tanacetum sinaicum (11, TS). Photographs of these plants growing in their wild habitat are displayed in Fig. 1 . Hepa1c1c7 cells were incubated for 48 h with increasing concentrations (0-50 lg/ml) of each extract, and the activity of the NQO1 marker enzyme was quantified using the Prochaska assay. P. incisa (PI 1:1) resulted in the highest concentration-dependent induction of NQO1-specific enzyme activity, as shown in Fig. 2 and Table 1 , where its CD value (the concentration needed to double the NQO1 activity by two-fold relative to the solvent control) was 3.2 lg/ml. At 50 lg/ml (the highest concentration tested), the PI 1:1 extract led to a robust eight-fold induction of NQO1-specific enzyme activity.
In contrast to the potent NQO1 inducer activity produced by the non-polar P. incisa extract (PI 1:1), the methanol:water (7:3) extract of this Pulicaria species (PI 70) caused a much weaker inducer activity (1.9-fold increase of NQO1 activity over vehicle control) at the highest concentration of 50 lg/ml. Dose-dependent increases of NQO1 activity were found with extracts from P. undulata (PU 1:1), S. herba-alba (both SH 1:1 and SH 70), and T. sinaicum (both TS 1:1 and TS70 extracts) with CD values ranging between 5.0 and 10.0 lg/ml ( Fig. 2 ; Table 1 ). Moderate NQO1 inducer activities (CD value between 12.0 and 16.0 lg/ml) were recorded for extracts from A. fragrantissima (AF 1:1 and AF 70) and A. judaica (AJ 1:1). Some of the tested extracts were weak NQO1 inducers, including B. undulata (BU 1:1, CD 22 lg/ml), E. santa-catherine (ES 70, CD 31 lg/ml), T. polium (TP 1:1, CD 28) and S. aegyptiaca (SA 70, CD 50 lg/ml). The remaining tested plant extracts were devoid of pronounced NQO1 inducer activity as they failed to reach a CD value even at the highest concentration of 50 lg/ml.
Because the NQO1 screening assay showed that the PI 1:1 extract has the most potent concentration-dependent induction of NQO1-specific enzyme activity ( Fig. 2 ; Table 1 ), we focused our subsequent studies on this extract. The gene expression of NQO1 is mediated primarily through the activity of transcription factor Nrf2. Under basal conditions, Nrf2 is bound to its main negative regulator, Kelch-like ECH-associated protein 1 (KEAP1), which serves as a substrate adaptor protein for a Cullin-3/ Rbx1 ubiquitin ligase and mediates the continuous ubiquitination and proteasomal degradation of Nrf2. KEAP1 is also a cysteine-based sensor for various endogenous and exogenous sulfhydryl-reactive small molecules (termed inducers), such as the isothiocyanate sulforaphane. Such compounds react and chemically modify the cysteine sensor(s) of Keap1 and disable its substrate adaptor activity, resulting in rapid stabilization of Nrf2. Therefore, we next examined the protein levels of Nrf2 after 4 h of exposure of Hepa1c1c7 cells to the PI 1:1 extract. As expected, based on NQO1 inducer activity, treatment with the PI 1:1 extract led to a concentration-dependent increase in the protein levels of Nrf2 (Fig. 3a) .
Simultaneous induction of HO-1 expression, another Nrf2-target protein, was also evident at the 4-h time point. In agreement with the enzyme activity assay, the levels of NQO1 protein were also dose-dependently upregulated by exposure to the PI 1:1 extract for 24 h (Fig. 3b) . Finally, we examined levels of GST-Pi, another member of the Nrf2-regulated cytoprotective proteome after 24 h of treatment with PI 1:1. GST-Pi was found to be upregulated coordinately with HO-1 and NQO1. Notably, the increases in HO-1 and NQO1 were much more pronounced than the increase in GST-Pi (Fig. 3c) , further supporting the use of NQO1 as a sensitive marker for Nrf2 activation.
Our study discovered the value of the P. incisa nonpolar extract (PI 1:1) as an activator of the Nrf2-dependent enzyme NQO1. These interesting results warrant further fractionation and isolation of the chemical constituents of this plant extract using bioassay-guided isolation schemes, which is underway.
